Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 7,571 | 6,862 | 2,318 | 839 |
| Operating Income | -7,571 | -6,862 | -2,318 | -839 |
| Interest Expense | 786 | 519 | 140 | 0 |
| Other Income | 403 | 0 | 0 | 244 |
| Pre-tax Income | -7,955 | -7,381 | -2,459 | -595 |
| Net Income Continuous | -7,955 | -7,381 | -2,459 | -595 |
| Net Income | $-7,955 | $-7,381 | $-2,459 | $-595 |
| EPS Basic Total Ops | -14.30 | -57.80 | -56.50 | N/A |
| EPS Basic Continuous Ops | -14.27 | -57.80 | -56.52 | N/A |
| EPS Diluted Total Ops | -14.30 | -57.80 | -56.50 | N/A |
| EPS Diluted Continuous Ops | -14.27 | -57.80 | -56.52 | N/A |
| EPS Diluted Before Non-Recurring Items | -14.30 | -57.80 | -6.30 | N/A |
| EBITDA(a) | $-6,879 | $-6,674 | $-2,178 | $-839 |